ursodeoxycholic acid and s-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy: a meta-analysis

نویسندگان

yang zhang medical college, qingdao university, qingdao, china; department of gastroenterology, qingdao municipal hospital, qingdao, china

linlin lu digestive disease key laboratory of qingdao, qingdao, china; central laboratories, qingdao municipal hospital, qingdao, china

david w victor hepatology and transplant medicine, department of medicine, houston methodist hospital, houston, usa

yongning xin medical college, qingdao university, qingdao, china; department of gastroenterology, qingdao municipal hospital, qingdao, china; digestive disease key laboratory of qingdao, qingdao, china; department of gastroenterology, qingdao municipal hospital, qingdao, shandong province, china. tel: +86-53282789463, fax: +86-53285968434

چکیده

conclusions udca decreased the pruritus score, tba, and alt levels more effectively than same, reducing the rate of preterm delivery for icp. evidence acquisition a meta-analysis of all randomized controlled trials (rcts) comparing udca, same, and combination therapy was performed. we carried out a literature search using pubmed, embase, the cochrane register of controlled trials, and the science citation index of web of science. the maternal clinical and biochemical responses, including pruritus scores, total bilirubin, total bile acids, alanine aminotransferase, and aspartate transaminase, were evaluated. safety assessments, including preterm delivery, cesarean section, and meconium-stained amniotic fluid, were also analyzed. results five rcts including 311 patients were evaluated. in comparison to same, udca significantly reduced the pruritus score (or = -0.45, 95% confidence interval [ci]: -0.66 to -0.25, p < 0.0001) and improved the levels of total bile acids (tbas; or = -0.59, 95% ci: -0.99 to –0.30, p < 0.0001) and alanine aminotransferase (alt; or = -0.38, 95% ci: -0.66 to -0.09, p = 0.01). udca was associated with significantly lower preterm delivery rates than same (rr = 0.48, 95% ci: 0.32–0.72, p = 0.0004). interestingly, combination therapy significantly reduced total bilirubin (tb; vs. same, or = -0.41, 95% ci, -0.74 to -0.08, p = 0.02), aspartate transaminase (ast; vs. udca, or = -0.40, 95% ci, -0.74 to –0.06, p = 0.02), and the rate of preterm delivery (vs. same, or = 0.62, 95% ci, 0.42 - 0.91, p = 0.02), in comparison with either drug administered alone. context an optimal therapeutic strategy has not yet been identified for the pharmacological treatment of intrahepatic cholestasis of pregnancy (icp). the aim of this study was to evaluate the efficacy and safety of ursodeoxycholic acid (udca) and s-adenosylmethionine (same) in the treatment of icp, both individually and in combination.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis

CONTEXT An optimal therapeutic strategy has not yet been identified for the pharmacological treatment of intrahepatic cholestasis of pregnancy (ICP). The aim of this study was to evaluate the efficacy and safety of ursodeoxycholic acid (UDCA) and S-adenosylmethionine (SAMe) in the treatment of ICP, both individually and in combination. EVIDENCE ACQUISITION A meta-analysis of all randomized co...

متن کامل

Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid

BACKGROUND To exam the biochemical, obstetric management and pregnancy outcome in women with intrahepatic cholestasis of pregnancy (ICP) and treatment with ursodeoxycholic acid (UDCA). METHODS Pregnancy outcome in patients with ICP (N = 307) was studied and patients treated with UDCA (N = 208) vs. no UDCA were compared. The data of the antenatal visits, deliveries and neonatal outcome of 307 ...

متن کامل

Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.

Intrahepatic cholestasis of pregnancy (ICP) is a disease characterized by generalized pruritus and biochemical cholestasis that appears typically during the last trimester of gestation. The most predictive and accurate markers for diagnosis and follow-up of ICP are increased total bile acid levels (above 11,0 micromol/L), enhanced cholic acid percentage (above 42%) and decreased glycine/taurine...

متن کامل

Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study): Erratum

BACKGROUND Intrahepatic cholestasis of pregnancy (ICP) is a specific pregnancy-related disorder without standard medical therapies. Ursodeoxycholic acid (UDCA) is the most used medicine, but the efficacy and safety of UDCA remain uncertain. Several meta-analyses had been made to assess the effects of UDCA in ICP. However, the samples were not large enough to convince obstetricians to use UDCA. ...

متن کامل

Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.

Intrahepatic cholestasis of pregnancy (ICP) is characterized by troublesome maternal pruritus, elevated serum bile acids (> or =10 micromol/L) and increased fetal risk. Recently we determined a cutoff level of serum bile acids, > or =40 micromol/L, to be associated with impaired fetal outcome. We have now studied the effects of ursodeoxycholic acid (UDCA) and dexamethasone on pruritus, biochemi...

متن کامل

 Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.

UNLABELLED  Background and aims. Patients with intrahepatic cholestasis of pregnancy (ICP) benefit from ursodeoxycholic acid (UDCA) treatment. Since there is still certain reluctance to use UDCA in pregnant women, mainly due to warnings in the official SPC information in respective drug leaflets, our objective was to assess the efficacy and safety of UDCA during pregnancy. MATERIAL AND METHOD...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
hepatitis monthly

جلد ۱۶، شماره ۸، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023